Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Introduction/overview: gender-based differences in pharmacologic and toxicologic responses.

M S Christian1

  • 1Primedica Argus Research Laboratories, Inc, Horsham, Pennsylvania 19044, USA. mildred.Christian@primedica.com

International Journal of Toxicology
|August 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measures of low food variety and poor dietary quality in a cross-sectional study of London school children.

European journal of clinical nutrition·2018
Same author

Measuring diet in primary school children aged 8-11 years: validation of the Child and Diet Evaluation Tool (CADET) with an emphasis on fruit and vegetable intake.

European journal of clinical nutrition·2014
Same author

Introduction and history of the Hungarian project for monitoring suicide attempts in pregnant women.

Toxicology and industrial health·2008
Same author

Embryo-fetal toxicity signals for 17alpha-hydroxyprogesterone caproate in high-risk pregnancies: a review of the non-clinical literature for embryo-fetal toxicity with progestins.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2007
Same author

Safety assessment of aqueous olive pulp extract as an antioxidant or antimicrobial agent in foods.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2006
Same author

Developmental (embryo-fetal toxicity/teratogenicity) toxicity studies of synthetic crystalline lycopene in rats and rabbits.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2003

Gender significantly impacts how mammals, including humans, develop and respond to external agents. Recognizing and studying these sex-based differences in animal models is crucial for accurate drug safety and efficacy assessments in both sexes.

Area of Science:

  • Pharmacology and Toxicology
  • Developmental Biology
  • Comparative Medicine

Background:

  • Sex-based differences are a critical, yet often overlooked, factor in mammalian development and response to exogenous agents.
  • Historical and societal views on sex differences have influenced research and healthcare, potentially exacerbating health disparities.
  • Current methods for assessing drug efficacy and toxicity in humans are limited by insufficient consideration of gender-specific responses and inadequate animal models.

Purpose of the Study:

  • To highlight the critical importance of gender as a determinant in mammalian development and response to pharmaceuticals and other exogenous agents.
  • To advocate for the use of more relevant animal models that accurately reflect gender-based differences in drug metabolism, pharmacokinetics, and pharmacodynamics.
  • To emphasize the need to consider gender dynamics across the entire life cycle and potential interactions with dietary supplements.

Related Experiment Videos

Main Methods:

  • Reviewing the limitations of current animal models in demonstrating sex-based differences in drug effects.
  • Discussing the challenges posed by advances in metabolic, pharmacokinetic, and pharmacodynamic capabilities for risk assessment.
  • Introducing the use of genistein as a case study, examining its health benefits and effects in a multigeneration rat study.

Main Results:

  • Current animal models (e.g., rats, dogs) often fail to adequately represent human gender-specific responses due to differences in development, physiology, metabolism, or kinetics.
  • There is a critical need for improved nonclinical testing procedures that utilize the most relevant animal models to accurately estimate human risks.
  • The study of specific agents like genistein in multigeneration models is essential for understanding gender-based effects.

Conclusions:

  • Re-emphasizing the significance of gender-related differences in pharmaceutical use and response is vital for optimizing drug development.
  • Advances in scientific understanding necessitate the optimization of nonclinical testing procedures to identify both benefits and risks for human use across sexes.
  • A comprehensive approach considering gender across the life cycle and potential interactions with other agents is required for accurate risk-benefit assessments.